October 1, 2018 PR-M10-18-NI-004
DUBLIN /PRNewswire/ - The "Global Endometrial Cancer Therapeutics Market 2018-2022" report has been added to ResearchAndMarkets.com'soffering.
The Global Endometrial Cancer Therapeutics Market to grow at a CAGR of 5.17% during the period 2018-2022.
Global Endometrial Cancer Therapeutics Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Endometrial cancer is a type of uterine cancer, which begins in the layer of cells that form the lining (endometrium) of the uterus of women. Unopposed endometrial estrogen exposure such as estrogen replacement therapy during menopause is associated with increased risk of developing endometrial cancer among women.
According to the report, one driver influencing this market is the increasing prevalence of endometrial cancer. The prevalence of endometrial cancer has been increasing rapidly due to the changing lifestyle, which is contributing to the growth of the market across the globe. One trend affecting this market is immune therapy. Immune therapy, also known as biological therapy, is a type of cancer treatment that improves the defense mechanism of the body to fight against the cancer.
Further, the report states that one challenge affecting this market is the high cost associated with treatment. One of the most major challenges being faced in the global endometrial cancer therapeutics market is the high cost of treatment such as chemotherapy, lab tests, and oral medications.
Key vendors
Key Topics Covered:
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
PART 05: MARKET SIZING 2017-2022
PART 06: FIVE FORCES ANALYSIS
PART 07: PIPELINE
PART 08: MARKET SEGMENTATION BY PRODUCT
PART 09: CUSTOMER LANDSCAPE
PART 10: REGIONAL LANDSCAPE
PART 11: DECISION FRAMEWORK
PART 12: DRIVERS AND CHALLENGES
PART 13: MARKET TRENDS
PART 14: VENDOR LANDSCAPE
PART 15: VENDOR ANALYSIS
For more information about this report visit
https://www.researchandmarkets.com/research/xdhcls/global?w=5
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.